Author: Johnson & Johnson International (Singapore)

At a Patient Reception on 6th December 2025, 20 leaders from 17 patient advocacy groups from across Asia Pacific, Europe, and the United States shared their support for the need to strengthen shared decision-making in healthcare. On December 7, 2025, the ESMO Asia 2025 Symposium, ‘Advancing EGFRm NSCLC Treatment Through Shared Decision-Making’ that was organized by the European Society for Medical Oncology (ESMO) and where Johnson & Johnson was involved, highlighted the role of healthcare professionals not only in making sense of the data but also in helping patients and their families navigate complex decision-making. The symposium at the ESMO Asia…